All Press Releases
August 30, 2023
Recludix Pharma to Participate in Multiple Investor Conferences in September
July 20, 2023
Recludix Pharma Enters into a Strategic Collaboration with Sanofi to Advance Novel Oral STAT6 Inhibitor in Multiple Immunological and Inflammatory Indications
March 7, 2023
Recludix Pharma to Present at the Oppenheimer 33rd Annual Healthcare Conference
February 1, 2023
Recludix Pharma to Present at the Guggenheim Healthcare Talks Oncology Conference
January 6, 2023
Recludix Pharma to Present at the 41st Annual J.P. Morgan Healthcare Conference
October 20, 2022
Recludix Pharma Announces the Appointment of Accomplished Immunologist and Pharmacologist Paul A. Smith, Ph.D., as Senior Vice President of Biology
September 29, 2022